Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
Status:
RECRUITING
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
This is an investigator-initiated, single-arm, prospective clinical study to evaluate the efficacy and safety of heptapopal in the treatment of thrombocytopenia prior to elective surgery
Phase:
PHASE4
Details
Lead Sponsor:
The Third People's Hospital of Chengdu
Collaborator:
Affiliated Hospital of North Sichuan Medical College